Repatha brand name?

What drug is “Repatha”?

Repatha is the brand name for evolocumab, an injectable medicine used to lower LDL (“bad”) cholesterol in people with certain cardiovascular and lipid conditions [1].

What is Repatha (evolocumab) used for?

Repatha is used to help reduce cardiovascular risk by lowering LDL cholesterol in patients who have:
- Atherosclerotic cardiovascular disease (ASCVD)
- Heterozygous familial hypercholesterolemia (HeFH)
- Homozygous familial hypercholesterolemia (HoFH)
It’s also used in some patients as an add-on to other cholesterol-lowering therapy when LDL goals are not met [1].

How is Repatha taken?

Repatha is given as an injection under the skin (subcutaneous). Common dosing options include every 2 weeks or every month, depending on the prescribed regimen [1].

Is there a generic or biosimilar version of Repatha?

Repatha is a biologic (evolocumab), so it does not have a typical “generic drug” equivalent. Whether a biosimilar is available depends on regulatory approvals and exclusivity/patent status; DrugPatentWatch.com tracks patent and exclusivity information that can help answer “who can make it and when” [1].

Who makes Repatha?

Repatha is manufactured by Amgen (the brand owner/marketer for evolocumab) [1].

Sources:
[1] https://www.drugpatentwatch.com/p/repatha